Clinical trials: Primary Intracerebral Hemorrhage, open to volunteers
Cerebrovascular Disorders, Intracranial Hemorrhages
Statins for Treatment of Primary Intracerebral Hemorrhage
The STOP ICH trial is a multicenter, prospective, randomized, open-label, blinded end-point (PROBE) study designed to assess the efficacy and safety of atorvastatin in patients with intracerebral hemorrhage (ICH) presenting…
- Conditions
- Cerebrovascular Disorders, Intracranial Hemorrhages, Intracranial Hemorrhage, Intracerebral Haemorrhage
- Trial name
- STOP ICH (NCT07088250)
- Testing
- Atorvastatin Treatment, Best Medical Treatment
- Where
- 22 sites in China
- Volunteers
- 264 people
- Sponsor
- The Second Hospital of Anhui Medical University
Neurologic Disorders, Nervous System Diseases
Neurologic Stem Cell Treatment Study
This is a human clinical study involving the isolation of autologous bone marrow derived stem cells (BMSC) and transfer to the vascular system and inferior 1/3 of the nasal passages in order to determine if such a treatment will…
- Conditions
- Neurologic Disorders, Nervous System Diseases, Neurodegenerative Diseases, Neurological Disorders
- Trial name
- NEST (NCT02795052)
- Testing
- Intravenous and Intranasal BMSC
- Where
- 3 sites in United States, United Arab Emirates
- Volunteers
- 500 people
- Sponsor
- MD Stem Cells
Primary Intracerebral Hemorrhage
Biomarkers for Cognitive Decline in Intracerebral Hemorrhage
The goal of this clinical trial is to see if silent brain infarcts (SBIs), or stroke-like symptoms detectable during brain imaging, are a possible contributor to cognitive decline for patients diagnosed with spontaneous…
- Trial name
- NCT06836141
- Testing
- MRI, Blood Draw, Cognitive Test
- Where
- United States
- Volunteers
- 118 people
- Sponsor
- Rush University Medical Center
Intracerebral Hemorrhage
GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized Trial
Intracerebral hemorrhage (ICH) is a devastating form of acute stroke with poor clinical outcomes. Although ICH accounted only for 28.8% of incident strokes, it was responsible for nearly half of the long-term burden of stroke…
- Trial name
- GLICH (NCT07613437)
- Testing
- Semaglutide, 0.5 mg/mL
- Where
- 3 sites in China, Hong Kong
- Volunteers
- 200 people
- Sponsor
- Chinese University of Hong Kong
Intracerebral Hemorrhage, Hemorrhagic Stroke, Intracerebral
Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial
This study is designed to determine the safety and feasibility of using Cerebrolysin in treating primary intracerebral hemorrhage (ICH).
- Conditions
- Intracerebral Hemorrhage, Hemorrhagic Stroke, Intracerebral, Hemorrhagic Stroke, Stroke
- Trial name
- CLINCH (NCT06899464)
- Testing
- 14-day Cerebrolysin treatment, Standard of Care (SOC)
- Volunteers
- 30 people
- Sponsor
- Cardinal Stefan Wyszynski University
Stroke, Intracerebral Hemorrhage
Clinical Outcomes Following Primary Intracerebral Hemorrhage
The investigators design an observational multi-center cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，cost-effective ,treatments and prognosis of Chinese hospitalized…
- Trial name
- COPI (NCT06548737)
- Where
- China
- Volunteers
- 25,000 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Intracerebral Hemorrhage
Prospective Cohort Study of Intracerebral Hemorrhage
The investigators design a prospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，cost-effective ,treatments and prognosis of Chinese hospitalised adult…
- Trial name
- POSTER (NCT04707105)
- Where
- China
- Volunteers
- 856 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine